SciTech Readies for First-In-Human Trial with Clinical Supply of ST-001 nanoFenretinide
SciTech Readies for First-In-Human Trial with Clinical Supply of ST-001 nanoFenretinide NEWS PROVIDED BY SciTech Development, LLC 03 Oct, 2023, 17:19 ET GROSSE POINTE FARMS, Mich., Oct. 3, 2023 /PRNewswire/ –.SciTech announced today that it has successfully manufactured the clinical supply of its lead drug candidate, ST-001 nanoFenretinide, to initiate its upcoming clinical trial in T-cell…